Healthcare Policy and Opinion

Hospitalization is not a question of being in the hospital and receiving treatment; discharge is a major factor. As a hospital patient, have you wanted...

Psychedelics and Mental Health

Michael Hunter, MD - May 4, 2023

THERE IS A GROWING INTEREST IN HALLUCINOGENS, especially regarding their application for psychiatric disorders.

A Digital Turning Point in Migraine Care: CT-132 FDA Approval to Market is a Win for Patients and Proof that Clinical Evidence Matters

Gil Bashe, Medika Life Editor - April 15, 2025

First Digital Health App United States Approval for Migraine Treatment with a Comprehensive Indication of Use

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Your Physician Knows What You Need. The System Won’t Let Them Give It to You.

When Science Advances, Why Does Society Doubt Its Own Progress?

Rethinking vaccine costs: how the “more expensive” vaccine can actually save health systems millions

Patient Dies by Suicide After ‘Insurance Issue’ Delayed Medicine for Lung Disease Flare-Ups

LATEST

TRENDING

Pfizer Confirms mRNA Vaccine Never Tested for Preventing COVID Transmission

The Medika Life Top 30 Voices Transforming Wellness for 2022/23

The Medika Life 50 – The Most Influential Voices in Health for 2022

Medika’s Top 20 AI Voices to Watch. Follow These Experts as They Demystify AI and Its Future

Women Transforming Healthcare: The Medika Life 2022 Top 30

Is the Covid Vaccine’s Spike Protein Killing Us?

Jackie Kennedy and Jane Fonda — Same Diagnosis, Different Decades and Treatments

Fifty of the Most Influential Voices in Healthcare for 2021

How Geert Vanden Bossche is Destroying American Herd Immunity

We Know the Health Ecosystem is Fragmented, Resulting in Rising Costs and Poorer Patient Outcomes, But What Are We Doing About It?

EDITORS CHOICE

The Lifelong Exercise That Keeps Japanese Moving

Uncovering Hidden, Frustrating Loopholes of the Arcane DRGs in Healthcare

Psychedelics and Mental Health

A Digital Turning Point in Migraine Care: CT-132 FDA Approval to Market is a Win for Patients and Proof that Clinical Evidence Matters

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories